Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NT5C3B | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
mRNA | MOSPD2 | FIMM | pan-cancer | AAC | 0.5 | 0.003 |
mRNA | HERC4 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | H3F3C | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | BMP2K | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RNF123 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | JAK2 | FIMM | pan-cancer | AAC | 0.52 | 0.003 |
mRNA | ZBTB7B | FIMM | pan-cancer | AAC | -0.52 | 0.003 |
mRNA | PARN | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
mRNA | BCL11B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |